Details for New Drug Application (NDA): 204626
✉ Email this page to a colleague
The generic ingredient in LEVOCETIRIZINE DIHYDROCHLORIDE is levocetirizine dihydrochloride. There are thirteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.
Summary for 204626
Tradename: | LEVOCETIRIZINE DIHYDROCHLORIDE |
Applicant: | Ipca Labs Ltd |
Ingredient: | levocetirizine dihydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 6, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription